Applications of MALDI-TOF mass spectrometry in clinical proteomics

V. Greco, C. Piras, L. Pieroni, M. Ronci, L. Putignani, P. Roncada, Andrea Urbani

Research output: Contribution to journalArticle

Abstract

Introduction: The development of precision medicine requires advanced technologies to address the multifactorial disease stratification and to support personalized treatments. Among omics techniques, proteomics based on Mass Spectrometry (MS) is becoming increasingly relevant in clinical practice allowing a phenotypic characterization of the dynamic functional status of the organism. From this perspective, Matrix Assisted Laser Desorption Ionization Time of Flight (MALDI-TOF) MS is a suitable platform for providing a high-throughput support to clinics. Areas covered: This review aims to provide an updated overview of MALDI-TOF MS applications in clinical proteomics. The most relevant features of this analysis have been discussed, highlighting both pre-analytical and analytical factors that are crucial in proteomics studies. Particular emphasis is placed on biofluids proteomics for biomarkers discovery and on recent progresses in clinical microbiology, drug monitoring, and minimal residual disease (MRD). Expert commentary: Despite some analytical limitations, the latest technological advances together with the easiness of use, the low time and low cost consuming and the high throughput are making MALDI-TOF MS instruments very attractive for the clinical practice. These features offer a significant potential for the routine of the clinical laboratory and ultimately for personalized medicine. © 2018, © 2018 Informa UK Limited, trading as Taylor & Francis Group.
Original languageEnglish
Pages (from-to)683-696
Number of pages14
JournalExpert Review of Proteomics
Volume15
Issue number8
DOIs
Publication statusPublished - 2018

Fingerprint

Proteomics
Ionization
Mass spectrometry
Desorption
Mass Spectrometry
Lasers
Precision Medicine
Medicine
Throughput
Clinical laboratories
Microbiology
Drug Monitoring
Residual Neoplasm
Biomarkers
Technology
Costs and Cost Analysis
Monitoring
Pharmaceutical Preparations
Costs
Therapeutics

Keywords

  • protein, antibody affinity
  • biopsy
  • body fluid
  • concentration (parameters)
  • drug development
  • human
  • ionization
  • laser desorption ionization mass spectrometry
  • matrix assisted laser desorption ionization time of flight mass spectrometry
  • microbiology
  • minimal residual disease
  • nonhuman
  • protein analysis
  • proteomics
  • Review
  • tissues
  • ultrafiltration

Cite this

Applications of MALDI-TOF mass spectrometry in clinical proteomics. / Greco, V.; Piras, C.; Pieroni, L.; Ronci, M.; Putignani, L.; Roncada, P.; Urbani, Andrea.

In: Expert Review of Proteomics, Vol. 15, No. 8, 2018, p. 683-696.

Research output: Contribution to journalArticle

Greco, V, Piras, C, Pieroni, L, Ronci, M, Putignani, L, Roncada, P & Urbani, A 2018, 'Applications of MALDI-TOF mass spectrometry in clinical proteomics', Expert Review of Proteomics, vol. 15, no. 8, pp. 683-696. https://doi.org/10.1080/14789450.2018.1505510
Greco V, Piras C, Pieroni L, Ronci M, Putignani L, Roncada P et al. Applications of MALDI-TOF mass spectrometry in clinical proteomics. Expert Review of Proteomics. 2018;15(8):683-696. https://doi.org/10.1080/14789450.2018.1505510
Greco, V. ; Piras, C. ; Pieroni, L. ; Ronci, M. ; Putignani, L. ; Roncada, P. ; Urbani, Andrea. / Applications of MALDI-TOF mass spectrometry in clinical proteomics. In: Expert Review of Proteomics. 2018 ; Vol. 15, No. 8. pp. 683-696.
@article{f005a23dd7994177b7c1498c65b4ac71,
title = "Applications of MALDI-TOF mass spectrometry in clinical proteomics",
abstract = "Introduction: The development of precision medicine requires advanced technologies to address the multifactorial disease stratification and to support personalized treatments. Among omics techniques, proteomics based on Mass Spectrometry (MS) is becoming increasingly relevant in clinical practice allowing a phenotypic characterization of the dynamic functional status of the organism. From this perspective, Matrix Assisted Laser Desorption Ionization Time of Flight (MALDI-TOF) MS is a suitable platform for providing a high-throughput support to clinics. Areas covered: This review aims to provide an updated overview of MALDI-TOF MS applications in clinical proteomics. The most relevant features of this analysis have been discussed, highlighting both pre-analytical and analytical factors that are crucial in proteomics studies. Particular emphasis is placed on biofluids proteomics for biomarkers discovery and on recent progresses in clinical microbiology, drug monitoring, and minimal residual disease (MRD). Expert commentary: Despite some analytical limitations, the latest technological advances together with the easiness of use, the low time and low cost consuming and the high throughput are making MALDI-TOF MS instruments very attractive for the clinical practice. These features offer a significant potential for the routine of the clinical laboratory and ultimately for personalized medicine. {\circledC} 2018, {\circledC} 2018 Informa UK Limited, trading as Taylor & Francis Group.",
keywords = "protein, antibody affinity, biopsy, body fluid, concentration (parameters), drug development, human, ionization, laser desorption ionization mass spectrometry, matrix assisted laser desorption ionization time of flight mass spectrometry, microbiology, minimal residual disease, nonhuman, protein analysis, proteomics, Review, tissues, ultrafiltration",
author = "V. Greco and C. Piras and L. Pieroni and M. Ronci and L. Putignani and P. Roncada and Andrea Urbani",
note = "cited By 1",
year = "2018",
doi = "10.1080/14789450.2018.1505510",
language = "English",
volume = "15",
pages = "683--696",
journal = "Expert Review of Proteomics",
issn = "1478-9450",
publisher = "Taylor and Francis Ltd.",
number = "8",

}

TY - JOUR

T1 - Applications of MALDI-TOF mass spectrometry in clinical proteomics

AU - Greco, V.

AU - Piras, C.

AU - Pieroni, L.

AU - Ronci, M.

AU - Putignani, L.

AU - Roncada, P.

AU - Urbani, Andrea

N1 - cited By 1

PY - 2018

Y1 - 2018

N2 - Introduction: The development of precision medicine requires advanced technologies to address the multifactorial disease stratification and to support personalized treatments. Among omics techniques, proteomics based on Mass Spectrometry (MS) is becoming increasingly relevant in clinical practice allowing a phenotypic characterization of the dynamic functional status of the organism. From this perspective, Matrix Assisted Laser Desorption Ionization Time of Flight (MALDI-TOF) MS is a suitable platform for providing a high-throughput support to clinics. Areas covered: This review aims to provide an updated overview of MALDI-TOF MS applications in clinical proteomics. The most relevant features of this analysis have been discussed, highlighting both pre-analytical and analytical factors that are crucial in proteomics studies. Particular emphasis is placed on biofluids proteomics for biomarkers discovery and on recent progresses in clinical microbiology, drug monitoring, and minimal residual disease (MRD). Expert commentary: Despite some analytical limitations, the latest technological advances together with the easiness of use, the low time and low cost consuming and the high throughput are making MALDI-TOF MS instruments very attractive for the clinical practice. These features offer a significant potential for the routine of the clinical laboratory and ultimately for personalized medicine. © 2018, © 2018 Informa UK Limited, trading as Taylor & Francis Group.

AB - Introduction: The development of precision medicine requires advanced technologies to address the multifactorial disease stratification and to support personalized treatments. Among omics techniques, proteomics based on Mass Spectrometry (MS) is becoming increasingly relevant in clinical practice allowing a phenotypic characterization of the dynamic functional status of the organism. From this perspective, Matrix Assisted Laser Desorption Ionization Time of Flight (MALDI-TOF) MS is a suitable platform for providing a high-throughput support to clinics. Areas covered: This review aims to provide an updated overview of MALDI-TOF MS applications in clinical proteomics. The most relevant features of this analysis have been discussed, highlighting both pre-analytical and analytical factors that are crucial in proteomics studies. Particular emphasis is placed on biofluids proteomics for biomarkers discovery and on recent progresses in clinical microbiology, drug monitoring, and minimal residual disease (MRD). Expert commentary: Despite some analytical limitations, the latest technological advances together with the easiness of use, the low time and low cost consuming and the high throughput are making MALDI-TOF MS instruments very attractive for the clinical practice. These features offer a significant potential for the routine of the clinical laboratory and ultimately for personalized medicine. © 2018, © 2018 Informa UK Limited, trading as Taylor & Francis Group.

KW - protein, antibody affinity

KW - biopsy

KW - body fluid

KW - concentration (parameters)

KW - drug development

KW - human

KW - ionization

KW - laser desorption ionization mass spectrometry

KW - matrix assisted laser desorption ionization time of flight mass spectrometry

KW - microbiology

KW - minimal residual disease

KW - nonhuman

KW - protein analysis

KW - proteomics

KW - Review

KW - tissues

KW - ultrafiltration

U2 - 10.1080/14789450.2018.1505510

DO - 10.1080/14789450.2018.1505510

M3 - Article

VL - 15

SP - 683

EP - 696

JO - Expert Review of Proteomics

JF - Expert Review of Proteomics

SN - 1478-9450

IS - 8

ER -